XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Class A and Class B Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Mar. 31, 2020 76,287,000        
Beginning balance at Mar. 31, 2020 $ 81,458        
Ending balance (in shares) at Dec. 31, 2020 76,287,000        
Ending balance at Dec. 31, 2020 $ 81,458        
Beginning balance (in shares) at Mar. 31, 2020   68,566,000      
Beginning balance at Mar. 31, 2020 1,136 $ 68 $ 14,954 $ 0 $ (13,886)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 4,536   4,536    
Exercise of stock options (in shares)   9,290,000      
Exercise of stock options 4,453 $ 9 4,444    
Issuance of common stock in exchange for services (in shares)   22,000      
Issuance of common stock in exchange for services 34   34    
Repurchase and retirement of common stock (in shares)   (58,000)      
Repurchase and retirement of common stock (370)   (370)    
Common stock warrant expense 162   162    
Other comprehensive income (loss) (2)     (2)  
Issuance of common stock in connection with an acquisition (in shares)   690,000      
Issuance of common stock in connection with an acquisition 1,062 $ 1 1,061    
Net income 28,727       28,727
Ending balance (in shares) at Dec. 31, 2020   78,510,000      
Ending balance at Dec. 31, 2020 $ 39,738 $ 78 24,821 (2) 14,841
Beginning balance (in shares) at Sep. 30, 2020 76,287,000        
Beginning balance at Sep. 30, 2020 $ 81,458        
Ending balance (in shares) at Dec. 31, 2020 76,287,000        
Ending balance at Dec. 31, 2020 $ 81,458        
Beginning balance (in shares) at Sep. 30, 2020   77,190,000      
Beginning balance at Sep. 30, 2020 19,325 $ 76 21,639 0 (2,390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 2,280   2,280    
Exercise of stock options (in shares)   1,378,000      
Exercise of stock options 1,179 $ 2 1,177    
Repurchase and retirement of common stock (in shares)   (58,000)      
Repurchase and retirement of common stock (370)   (370)    
Common stock warrant expense 95   95    
Other comprehensive income (loss) (2)     (2)  
Net income 17,231       17,231
Ending balance (in shares) at Dec. 31, 2020   78,510,000      
Ending balance at Dec. 31, 2020 $ 39,738 $ 78 24,821 (2) 14,841
Beginning balance (in shares) at Mar. 31, 2021 76,286,618        
Beginning balance at Mar. 31, 2021 $ 81,458        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Conversion of redeemable convertible preferred stock upon initial public offering (in shares) (76,287,000)        
Conversion of redeemable convertible preferred stock upon initial public offering $ (81,458)        
Ending balance (in shares) at Dec. 31, 2021 0        
Ending balance at Dec. 31, 2021 $ 0        
Beginning balance (in shares) at Mar. 31, 2021   82,910,000      
Beginning balance at Mar. 31, 2021 66,743 $ 83 30,357 (21) 36,324
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation $ 20,681   20,681    
Exercise of stock options (in shares) 8,536,000 8,536,000      
Exercise of stock options $ 9,314 $ 9 9,305    
Vesting of restricted stock units (in shares)   13,000      
Tax withholding on shares under stock-based compensation awards (436)   (436)    
Repurchase and retirement of common stock (in shares)   (181,000)      
Repurchase and retirement of common stock (2,698)   (2,698)    
Common stock warrant expense 1,269   1,269    
Other comprehensive income (loss) (3,992)     (3,992)  
Conversion of redeemable convertible preferred stock upon initial public offering (in shares)   76,287,000      
Conversion of redeemable convertible preferred stock upon initial public offering 81,458 $ 76 81,382    
Issuance of common stock upon initial public offering, net of underwriting discounts and offering costs (in shares)   22,506,000      
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and deferred offering costs 548,452 $ 22 548,430    
Net income 118,057       118,057
Ending balance (in shares) at Dec. 31, 2021   190,071,000      
Ending balance at Dec. 31, 2021 $ 838,848 $ 190 688,290 (4,013) 154,381
Beginning balance (in shares) at Sep. 30, 2021 0        
Beginning balance at Sep. 30, 2021 $ 0        
Ending balance (in shares) at Dec. 31, 2021 0        
Ending balance at Dec. 31, 2021 $ 0        
Beginning balance (in shares) at Sep. 30, 2021   186,971,000      
Beginning balance at Sep. 30, 2021 772,560 $ 187 674,414 (775) 98,734
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 8,765   8,765    
Exercise of stock options (in shares)   3,090,000      
Exercise of stock options 4,249 $ 3 4,246    
Vesting of restricted stock units (in shares)   10,000      
Tax withholding on shares under stock-based compensation awards (380)   (380)    
Common stock warrant expense 1,245   1,245    
Other comprehensive income (loss) (3,238)     (3,238)  
Net income 55,647       55,647
Ending balance (in shares) at Dec. 31, 2021   190,071,000      
Ending balance at Dec. 31, 2021 $ 838,848 $ 190 $ 688,290 $ (4,013) $ 154,381